147 related articles for article (PubMed ID: 35743212)
1. Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer.
Tohi Y; Taoka R; Zhang X; Matsuoka Y; Yoshihara A; Ibuki E; Haba R; Akimitsu K; Izumori K; Kakehi Y; Sugimoto M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743212
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of D-allose: up-regulation of thioredoxin-interacting protein in head and neck cancer cells.
Hoshikawa H; Mori T; Mori N
Ann Otol Rhinol Laryngol; 2010 Aug; 119(8):567-71. PubMed ID: 20860283
[TBL] [Abstract][Full Text] [Related]
3. Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1.
Yamaguchi F; Takata M; Kamitori K; Nonaka M; Dong Y; Sui L; Tokuda M
Int J Oncol; 2008 Feb; 32(2):377-85. PubMed ID: 18202760
[TBL] [Abstract][Full Text] [Related]
4. Rare sugar D-allose strongly induces thioredoxin-interacting protein and inhibits osteoclast differentiation in Raw264 cells.
Yamada K; Noguchi C; Kamitori K; Dong Y; Hirata Y; Hossain MA; Tsukamoto I; Tokuda M; Yamaguchi F
Nutr Res; 2012 Feb; 32(2):116-23. PubMed ID: 22348460
[TBL] [Abstract][Full Text] [Related]
5. D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression.
Noguchi C; Kamitori K; Hossain A; Hoshikawa H; Katagi A; Dong Y; Sui L; Tokuda M; Yamaguchi F
Tohoku J Exp Med; 2016 Feb; 238(2):131-41. PubMed ID: 26829886
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant properties of rare sugar D-allose: Effects on mitochondrial reactive oxygen species production in Neuro2A cells.
Ishihara Y; Katayama K; Sakabe M; Kitamura M; Aizawa M; Takara M; Itoh K
J Biosci Bioeng; 2011 Dec; 112(6):638-42. PubMed ID: 21889400
[TBL] [Abstract][Full Text] [Related]
7. Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7.
Yamaguchi F; Kamitori K; Sanada K; Horii M; Dong Y; Sui L; Tokuda M
J Biosci Bioeng; 2008 Sep; 106(3):248-52. PubMed ID: 18930000
[TBL] [Abstract][Full Text] [Related]
8. Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation.
Samukawa Y; Ouchi Y; Miyashita T; Rahman A; Tsukamoto I; Yoshihara A; Hoshikawa H
Anticancer Res; 2024 May; 44(5):1895-1903. PubMed ID: 38677730
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with D-allose, docetaxel and radiation inhibits the tumor growth in an
Hoshikawa H; Kamitori K; Indo K; Mori T; Kamata M; Takahashi T; Tokuda M
Oncol Lett; 2018 Mar; 15(3):3422-3428. PubMed ID: 29456721
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the inhibitory mechanism of D-allose on MOLT-4F leukemia cell proliferation.
Hirata Y; Saito M; Tsukamoto I; Yamaguchi F; Sui L; Kamitori K; Dong Y; Uehara E; Konishi R; Janjua N; Tokuda M
J Biosci Bioeng; 2009 May; 107(5):562-8. PubMed ID: 19393559
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the radiation effects by D-allose in head and neck cancer cells.
Hoshikawa H; Indo K; Mori T; Mori N
Cancer Lett; 2011 Jul; 306(1):60-6. PubMed ID: 21439723
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect and possible mechanisms of D-allose on cancer cell proliferation.
Sui L; Dong Y; Watanabe Y; Yamaguchi F; Hatano N; Tsukamoto I; Izumori K; Tokuda M
Int J Oncol; 2005 Oct; 27(4):907-12. PubMed ID: 16142305
[TBL] [Abstract][Full Text] [Related]
13. D-allose: Molecular Pathways and Therapeutic Capacity in Cancer.
Khajeh S; Ganjavi M; Panahi G; Zare M; Zare M; Tahami SM; Razban V
Curr Mol Pharmacol; 2023; 16(8):801-810. PubMed ID: 36578261
[TBL] [Abstract][Full Text] [Related]
14. CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species.
Takeuchi H; Taoka R; Mmeje CO; Jinesh GG; Safe S; Kamat AM
Urol Oncol; 2016 Aug; 34(8):337.e11-8. PubMed ID: 27038699
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effects of D-allose associated with reduced cell division frequency in glioblastoma.
Suzuki K; Ogawa D; Kanda T; Fujimori T; Shibayama Y; Rahman A; Ye J; Ohsaki H; Akimitsu K; Izumori K; Tamiya T; Nishiyama A; Miyake K
Sci Rep; 2023 Nov; 13(1):19515. PubMed ID: 37945736
[TBL] [Abstract][Full Text] [Related]
16. Development of a d-allose-6-phosphate derivative with anti-proliferative activity against a human leukemia MOLT-4F cell line.
Ishiyama H; Yanagita RC; Takemoto K; Kobashi K; Sugiyama Y; Kawanami Y
Carbohydr Res; 2020 Jan; 487():107859. PubMed ID: 31751780
[TBL] [Abstract][Full Text] [Related]
17. Rhopaloic acid A induces apoptosis, autophagy and MAPK activation through ROS-mediated signaling in bladder cancer.
Hung SY; Chen WF; Lee YC; Su JH; Juan YS; Lin IP; Zhang YH; Chang MK; Lin MY; Chen CY; Lee CH
Phytomedicine; 2021 Nov; 92():153720. PubMed ID: 34481340
[TBL] [Abstract][Full Text] [Related]
18. Resiniferatoxin induces death of bladder cancer cells associated with mitochondrial dysfunction and reduces tumor growth in a xenograft mouse model.
Farfariello V; Liberati S; Morelli MB; Tomassoni D; Santoni M; Nabissi M; Giannantoni A; Santoni G; Amantini C
Chem Biol Interact; 2014 Dec; 224():128-35. PubMed ID: 25451591
[TBL] [Abstract][Full Text] [Related]
19. Cryoprotective effects of D-allose on mammalian cells.
Sui L; Nomura R; Dong Y; Yamaguchi F; Izumori K; Tokuda M
Cryobiology; 2007 Oct; 55(2):87-92. PubMed ID: 17645876
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibitory effect of D-allose on human ovarian carcinoma cells in vitro.
Sui L; Dong Y; Watanabe Y; Yamaguchi F; Hatano N; Izumori K; Tokuda M
Anticancer Res; 2005; 25(4):2639-44. PubMed ID: 16080505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
